InspireMD will announce Q1 2025 financial results on May 9, hosting a conference call at 8:30 a.m. ET.
Quiver AI Summary
InspireMD, Inc. has announced that it will release its financial results for the first quarter of 2025 on May 9, 2025. To discuss these results and recent company highlights, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time. Interested participants can join the call via telephone or access the live webcast through the company's website. A replay of the webinar will be available afterward. InspireMD focuses on developing its CGuard™ Prime carotid stent system and aims to set a new standard in carotid stenting with its MicroNet® technology. The company's stock is traded on Nasdaq under the ticker NSPR.
Potential Positives
- InspireMD is set to release its first quarter 2025 financial results, indicating transparency and a commitment to keeping investors informed.
- The company will host a conference call and webcast to discuss financial results and recent highlights, suggesting engagement with stakeholders and enhancing investor relations.
- The announcement demonstrates InspireMD's ongoing focus on utilizing its proprietary technology, MicroNet®, to position itself as a leader in carotid stenting, which could attract investor interest.
Potential Negatives
- The announcement of the upcoming financial results without any prior mention of expected performance may raise concerns among investors about the company's financial health and transparency.
- The need to host a conference call and webcast to discuss financial results might imply that previous reports or communication may have fallen short in adequately informing stakeholders.
- Information regarding the financial results is pending, which could lead to uncertainty and speculation about the company's performance in the market.
FAQ
When will InspireMD release its Q1 2025 financial results?
InspireMD will release its first quarter 2025 financial results on Friday, May 9, 2025.
How can I participate in InspireMD's earnings call?
Interested parties can access the call by dialing 1-800-579-2543 for domestic callers or 1-785-424-1789 for international callers.
What time is the InspireMD conference call scheduled?
The conference call is scheduled for 8:30 a.m. Eastern Time on May 9, 2025.
Will there be a replay of the InspireMD earnings call?
Yes, a replay of the webinar will be available shortly after the call concludes and will be archived on InspireMD's website.
Where can I find more information about InspireMD?
Additional information can be found on InspireMD's website at www.inspiremd.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$NSPR Hedge Fund Activity
We have seen 9 institutional investors add shares of $NSPR stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PARKMAN HEALTHCARE PARTNERS LLC added 750,635 shares (+721.2%) to their portfolio in Q4 2024, for an estimated $1,974,170
- NANTAHALA CAPITAL MANAGEMENT, LLC removed 535,028 shares (-24.2%) from their portfolio in Q4 2024, for an estimated $1,407,123
- ESSEX INVESTMENT MANAGEMENT CO LLC added 72,565 shares (+inf%) to their portfolio in Q4 2024, for an estimated $190,845
- MILLENNIUM MANAGEMENT LLC removed 68,819 shares (-17.2%) from their portfolio in Q4 2024, for an estimated $180,993
- MORGAN STANLEY added 34,807 shares (+38.9%) to their portfolio in Q4 2024, for an estimated $91,542
- COURIER CAPITAL LLC added 30,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $80,700
- NORTHERN TRUST CORP added 24,452 shares (+103.7%) to their portfolio in Q4 2024, for an estimated $64,308
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NSPR Analyst Ratings
Wall Street analysts have issued reports on $NSPR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Lake Street issued a "Buy" rating on 12/11/2024
To track analyst ratings and price targets for $NSPR, check out Quiver Quantitative's $NSPR forecast page.
Full Release
MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced that it will release its first quarter 2025 financial results on Friday, May 9, 2025. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights.
Interested parties may access the live earnings call via telephone by dialing 1-800-579-2543 for domestic callers or 1-785-424-1789 for international callers. The live webinar may be accessed by visiting InspireMD’s website or by registering below. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on InspireMD’s website.
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1713642&tp_key=1c3c464032
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet
®
technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free, long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit
www.inspiremd.com
.
Investor Contact:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
[email protected]
Webb Campbell
Gilmartin Group LLC
[email protected]
[email protected]
